The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SARC 028: A phase II study of the anti-PD1 antibody pembrolizumab (P) in patients (Pts) with advanced sarcomas.
 
Melissa Amber Burgess
No Relationships to Disclose
 
John Crowley
No Relationships to Disclose
 
Denise K. Reinke
No Relationships to Disclose
 
Richard F. Riedel
Employment - Biotech Prosthetic Orthotics of North Carolina (I)
Leadership - Biotech Prosthetic Orthotics of North Carolina (I)
Honoraria - Novartis
Consulting or Advisory Role - CytRx Corporation; GlaxoSmithKline; Merck; Morphotek; Novartis
Research Funding - ARIAD (Inst); Astex Pharmaceuticals (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst); ZIOPHARM Oncology (Inst)
Patents, Royalties, Other Intellectual Property - PandoNet - Limbguard (I)
Travel, Accommodations, Expenses - Novartis
 
Suzanne George
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie
Consulting or Advisory Role - ARIAD; Blueprint Medicines; Novartis; Pfizer
Research Funding - ARIAD (Inst); Bayer (Inst); Novartis (Inst); Pfizer (Inst)
 
Sujana Movva
No Relationships to Disclose
 
Brian Andrew Van Tine
No Relationships to Disclose
 
Lara Emily Davis
Consulting or Advisory Role - Foundation Medicine
Patents, Royalties, Other Intellectual Property - Patent application filed for Target Inhibition Maps, a computational algorithm to predict tumor drug sensitivity. Co-inventor (5%)
 
Scott Schuetze
No Relationships to Disclose
 
James Hu
No Relationships to Disclose
 
Steven Attia
Consulting or Advisory Role - EMD Serono
Research Funding - AB Science (Inst); CytRx Corporation (Inst); Infinity Pharmaceuticals (Inst); Morphotek (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst); ZIOPHARM Oncology (Inst)
 
Dennis A. Priebat
No Relationships to Disclose
 
Damon R. Reed
No Relationships to Disclose
 
Sandra P. D'Angelo
No Relationships to Disclose
 
Scott H. Okuno
No Relationships to Disclose
 
Robert G. Maki
Stock and Other Ownership Interests - Agios; Celgene; Epizyme; Gilead Sciences; Karyopharm Therapeutics
Consulting or Advisory Role - Arcus Ventures; Bayer; Eisai; Gem Pharmaceuticals; GlaxoSmithKline; Lilly/ImClone; SARC: Sarcoma Alliance for Research though Collaboration; TRACON Pharma
Research Funding - Eisai (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
Travel, Accommodations, Expenses - Bayer/Onyx; Janssen Oncology
 
Shreyaskumar Patel
No Relationships to Disclose
 
Laurence H. Baker
No Relationships to Disclose
 
Hussein Abdul-Hassan Tawbi
No Relationships to Disclose